The Journal of Practical Medicine >
Effects of different dose dexmedetomidine combined with sufentanil on perioperative analgesia and sleep quality in patients with oral cancer
Received date: 2025-04-07
Online published: 2025-07-29
Objective To investigate the effect of high, middle and low dose dexmedetomidine combined with sufentanil on perioperative analgesia and sleep quality in patients with oral cancer. Methods A total of 158 patients undergoing oral cancer surgery in the hospital from January 2023 to June 2024 were selected and divided into group A[n = 53,0.6 μg/(kg·h) dexmedetomidine + 2 μg/kg sufentanil]and group B[n = 53,0.4 μg/(kg·h) dexmedetomidine + 2 μg/kg sufentanil] , Group C [n = 52, 0.2 μg/(kg·h) dexmedetomidine + 2 μg/kg sufentanil]by random number table method. Stress response indexes [brain-derived neurotrophic factor (BDNF), cortisol (Cor), interleukin-6 (IL-6)], bifrequency index and analgcsia nociccption index(BIS, ANI), pain level, T lymphocyte subsets CD3+, CD4+, CD8+ levels, Richards Campbell Sleep Scale (RCSQ) score and adverse reactions were compared between the two groups. Results Compared with 12 h before surgery, serum levels of BDNF, Cor and IL-6 in 3 groups were decreased 48 h after surgery, group A was lower than group B, group C, group B was lower than group C(P < 0.05). Compared with T0, BIS at T1 ~ T3 were significantly different between the 3 groups (P < 0.05), BIS at T1 ~ T3 were lower than those at T0 (P < 0.05), and there was no significant difference in BIS at the same time between the 3 groups (P>0.05), from T1 to T3, ANI was higher than that at T0, and ANI in group A was higher than that in group B and group C (P < 0.05). Compared with the preoperative results, the pain scores of the 3 groups were decreased at 1 h, 6 h, 24 h and 48 h after operation, and the pain scores of group A were lower than those of group B and C, and the pain scores of group B were lower than those of group C (P < 0.05). After operation, CD3+ and CD4+ were decreased in all 3 groups, group A was lower than group B and group C, group B was lower than group C (P < 0.05), and CD8+ was increased in all 3 groups, group A was higher than group B and group C, group B was higher than group C (P < 0.05). Compared with 1 day before the operation, the sleep quality scores of the three groups on the night after the operation and the second night after the operation were all decreased, group A was lower than group B and group C, and group B was lower than group C(P < 0.05). The incidence of hypotension and sinus bradycardia in group A was higher than that in group B and group C (P < 0.05). There was no significant difference in the incidence of hypotension and sinus bradycardia between group B and group C (P > 0.05). There was no significant difference in the incidence of nausea, vomiting and dizziness among the three groups (P > 0.05). Conclusion The analgesic effect of 0.6 μg/(kg·h) dose dexmedetomidine combined with sufentanil can effectively reduce the body's stress response and immune suppression, improve sleep quality, but with a greater incidence of intraoperative hypotension and bradycardia.
Key words: oral cancer; dexmedetomidine; sufentanil; different doses; analgesia; sleep quality
Xiaomei BAO , Yu LIU , Chengcheng JIN , Luping. WANG . Effects of different dose dexmedetomidine combined with sufentanil on perioperative analgesia and sleep quality in patients with oral cancer[J]. The Journal of Practical Medicine, 2025 , 41(14) : 2250 -2257 . DOI: 10.3969/j.issn.1006-5725.2025.14.019
| [1] | SARODE G, MANIYAR N, SARODE S C, et al. Epidemiologic aspects of oral cancer[J]. Dis Mon,2020,66(12): 100988. doi:10.1016/j.disamonth.2020.100988 |
| [2] | MCGURK M, CHEGINI S, SCHILLING C, et al. What is the optimum operative approach for the N0 neck in patients with early mouth cancer-a review of current status[J]. Br J Oral Maxillofac Surg,2022,60(7):864-867. doi:10.1016/j.bjoms.2021.08.011 |
| [3] | INCHINGOLO A M, DIPALMA G, INCHINGOLO A D, et al. Advancing Postoperative Pain Management in Oral Cancer Patients: A Systematic Review[J]. Pharmaceuticals (Basel),2024,17(4):542. doi:10.3390/ph17040542 |
| [4] | NIE Z B, LI Z H, LU B, et al. Hydromorphone vs sufentanil in patient-controlled analgesia for postoperative pain management: A meta-analysis[J]. Medicine (Baltimore),2022,101(3):e28615. doi:10.1097/md.0000000000028615 |
| [5] | 谷梓毓,刘雨,丁怡彤,等. 右美托咪定用于患者自控式睡眠调节对胃肠肿瘤患者术后睡眠障碍的疗效[J]. 中华麻醉学杂志,2024,44(5):609-614. |
| [6] | 尚伟,郑家伟. 2019年NCCN口腔口咽癌诊疗指南更新解读[J]. 中国口腔颌面外科杂志,2019,17(6):481-485. |
| [7] | 孙兵,车晓明(整理. 视觉模拟评分法(VAS)[J]. 中华神经外科杂志,2012,28(6):645. |
| [8] | 杨贵亭,郭向阳,陶立元,等. 镇痛/伤害刺激指数与宫腔镜腰麻后低血压的相关性研究[J]. 中国微创外科杂志,2019,19(3):193-196. |
| [9] | 陈丽霞,纪代红,赵巧玉,等. 中文版理查兹-坎贝尔睡眠量表的信效度研究[J]. 中华护理杂志,2016,51(9):1141-1144. |
| [10] | WARNAKULASURIYA S, KUJAN O, AGUIRRE-URIZAR J M,et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer[J]. Oral Dis,2021,27(8):1862-1880. doi:10.1111/odi.13704 |
| [11] | ZHANG W, ZHU H, YE P. Unplanned reoperation after radical surgery for oral cancer: An analysis of risk factors and outcomes[J]. BMC Oral Health,2022,22(1):204. doi:10.1186/s12903-022-02238-7 |
| [12] | BROUWER KONING S G, SCHAEFFERS A W M A, SCHATS W,et al. Assessment of the deep resection margin during oral cancer surgery: A systematic review[J]. Eur J Surg Oncol,2021,47(9):2220-2232. doi:10.1016/j.ejso.2021.04.016 |
| [13] | 陶芸生,江昭林,甘泉,等. 不同剂量右美托咪定联合舒芬太尼对全髋关节置换术患者术中及术后的影响[J]. 中国骨与关节杂志,2021,10(7):527-532. |
| [14] | 罗莹,韩宏雨,程守全,等. 不同剂量右美托咪定联合舒芬太尼对老年全髋关节置换术患者血流动力学,脑保护效应和T淋巴细胞亚群的影响[J]. 现代生物医学进展,2022,22(10):1869-1874. |
| [15] | KOUSHIK S S, SCHWARTZ R H, CHERKALIN D, et al. A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures[J]. Curr Pain Headache Rep,2022,26(2):145-149. doi:10.1007/s11916-022-01014-0 |
| [16] | FONSECA N M, GUIMARAES G M N, PONTES J P J,et al. Safety and effectiveness of adding fentanyl or sufentanil to spinal anesthesia:Systematic review and meta-analysis of randomized controlled trials[J]. Braz J Anesthesiol,2023,73(2):198-216. doi:10.1016/j.bjane.2021.10.010 |
| [17] | 陈添辉,张莹珊,李集源,等. 右美托咪定辅助术后镇痛对老年患者腹部手术后睡眠质量的影响[J]. 临床麻醉学杂志,2024,40(9):928-932. |
| [18] | 侯艳华,张加强,武江霞. 不同麻醉方法对食管癌根治术患者术后睡眠质量的影响[J]. 中华麻醉学杂志,2020,40(4):500-501. |
| [19] | POON W H, LING R R, YANG I X,et al. Dexmedetomidine for adult cardiac surgery:A systematic review, meta-analysis and trial sequential analysis[J]. Anaesthesia,2023,78(3):371-380. doi:10.1111/anae.15947 |
| [20] | LAMSAL R, RATH G P, DUBE S K. Effect of Dexmedetomidine on Dynamic Cerebral Autoregulation in Patients Undergoing Supratentorial Tumor Surgery[J]. Neurol India,2025,73(2):280-285. doi:10.4103/neurol-india.neurol-india-d-24-00131 |
| [21] | TASBIHGOU S R, BARENDS C R M, ABSALOM A R. The role of dexmedetomidine in neurosurgery[J]. Best Pract Res Clin Anaesthesiol,2021,35(2):221-229. doi:10.1016/j.bpa.2020.10.002 |
| [22] | OZCAN E, OZCAN F G. Difficult Airway Management in Oromaxillofacial Tumor Surgery: Two Case Reports and Review of the Literature[J]. Indian J Otolaryngol Head Neck Surg, 2025,77(2):1088-1094. doi:10.1007/s12070-024-05274-7 |
| [23] | PATIL S, YADALAM P K, HOSMANI J,et al. Modulation of oral cancer and periodontitis using chemotherapeutic agents-A narrative review[J]. Dis Mon,2023,69(1):101348. doi:10.1016/j.disamonth.2022.101348 |
| [24] | MOLLER M H, ALHAZZANI W, LEWIS K,et al. Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients:A rapid practice guideline[J]. Intensive Care Med,2022,48(7):801-810. doi:10.1007/s00134-022-06660-x |
| [25] | BOSCH O G, DORNBIERER D A, BAVATO F,et al. Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties[J]. Pharmacopsychiatry,2023,56(2):44-50. |
| [26] | FABBRI M, BERACCI A, MARTONI M,et al. Measuring Subjective Sleep Quality: A Review[J]. Int J Environ Res Public Health,2021,18(3):1082. doi:10.3390/ijerph18031082 |
| [27] | RAIMANN F J, ADAM E, STROUHAL U,et al. Dexmedetomidine as adjunct in awake craniotomy-improvement or not?[J]. Anaesthesiol Intensive Ther,2020,52(1):15-22. doi:10.5114/ait.2020.93043 |
| [28] | ZHAO S, WU W, LIN X,et al. Protective effects of dexmedetomidine in vital organ injury: Crucial roles of autophagy[J]. Cell Mol Biol Lett,2022,27(1):34. doi:10.1186/s11658-022-00335-7 |
/
| 〈 |
|
〉 |